DJ Hardman & Co Q&A on Shield Therapeutics (STX): Positioned for profitability with Viatris deal and its additional capital Hardman & Co Research Hardman & Co Q&A on Shield Therapeutics (STX): Positioned
Defying market expectations, the BOJ kept its interest rate targets and policy of yield curve control intact, and instead crafted a new weapon to prevent long-term rates from rising too much in a show of resolve. The decision sent the dollar up some 2% against the yen, although it later pared gains to finish roughly 0.6% higher.
DJ Hardman & Co Research on Advanced Oncotherapy (AVO): Understanding the significance of 230MeV Hardman & Co Research Hardman & Co Research on Advanced Oncotherapy (AVO): Understanding the significance
DJ Hardman & Co Research on Apax Global Alpha (Initiation of coverage): Making pearls out of oysters Hardman & Co Research Hardman & Co Research on Apax Global Alpha (Initiation of coverage): Making